Prolonging the effects of botulinum therapy: A milestone in neuromuscular disease management
by Shimane UniversityAntibody administration following saline or BTX administration at the beginning of the treatment. Anti-IGF1R antibody treatment is denoted as IGF1R and control IgG antibody treatm
Updated on: January 10,2024
12
Prolonging the effects of botulinum therapy: A milestone in neuromuscular disease management
by Shimane UniversityAntibody administration following saline or BTX administration at the beginning of the treatment. Anti-IGF1R antibody treatment is denoted as IGF1R and control IgG antibody treatm
Updated on:January 10,2024
12